Our #RDH12 Families have been supporting the work of Dr. Moosajee @Moorfields. Dr. Moosajee recently published her work on characterizing cellular phenotypes due to the loss of #RDH12. https://t.co/EWayT6vwoC
Our #RDH12 Families have been supporting the work of Dr. Moosajee @Moorfields. Dr. Moosajee recently published her work on characterizing cellular phenotypes due to the loss of #RDH12. https://t.co/EWayT6vwoC
Our #RDH12 Families have been supporting the work of Dr. Moosajee @Moorfields. Dr. Moosajee recently published her work on characterizing cellular phenotypes due to the loss of #RDH12. https://t.co/EWayT6vwoC
Today is #WorldBrailleDay! Invented by Louis Braille in 1824, #braille is a tactile representation of alphabetic and numerical symbols that allows #blind and #visuallyimpaired individuals to read and write.
The RDH12 Fund for Sight helped to support the work in Dr. Bennett's lab to develop the #RDH12#GeneTherapy and the @ChildrensPhila natural history study.
The #RDH12#GeneTherapy being developed by @OpusGenetics was originated in the laboratory of Dr. Jean Bennett of @ChildrensPhila@Penn. Dr. Bennett has published a natural history study of RDH12 LCA. https://t.co/kFZcjwvXIR
The #RDH12#GeneTherapy being developed by @OpusGenetics was originated in the laboratory of Dr. Jean Bennett of @ChildrensPhila@Penn. Dr. Bennett has published a natural history study of RDH12 LCA. https://t.co/kFZcjwvXIR
The #RDH12#Genetherapy being developed by @MeiraGTx was created in the lab of Dr. Debra Thompson @UMKelloggEye@UMich. The preclinical data was published in 2019 https://t.co/jZaynYAcsI.
The #RDH12#Genetherapy being developed by @MeiraGTx was created in the lab of Dr. Debra Thompson @UMKelloggEye@UMich. The preclinical data was published in 2019 https://t.co/jZaynYAcsI.
The #RDH12#Genetherapy being developed by @MeiraGTx was created in the lab of Dr. Debra Thompson @UMKelloggEye@UMich. The preclinical data was published in 2019 https://t.co/jZaynYAcsI.
It is really encouraging to finally see not just one but two companies now taking meaningful steps forward on making #genetherapy for #RDH12 LCA a reality.
2022 could be the most impactful year yet in our journey toward a treatment for RDH12 LCA. @MeiraGTx has officially declared their intention to pursue a #genetherapy trial. https://t.co/4rxYBXJbtR
2022 could be the most impactful year yet in our journey toward a treatment for RDH12 LCA. @MeiraGTx has officially declared their intention to pursue a #genetherapy trial. https://t.co/4rxYBXJbtR